Singapore markets close in 7 hours 38 minutes
  • Straits Times Index

    3,189.77
    -19.09 (-0.59%)
     
  • Nikkei

    31,375.24
    -384.64 (-1.21%)
     
  • Hang Seng

    17,809.66
    +436.66 (+2.51%)
     
  • FTSE 100

    7,510.72
    -97.36 (-1.28%)
     
  • Bitcoin USD

    27,450.26
    -422.39 (-1.52%)
     
  • CMC Crypto 200

    587.57
    -15.97 (-2.65%)
     
  • S&P 500

    4,288.39
    +0.34 (+0.01%)
     
  • Dow

    33,433.35
    -74.15 (-0.22%)
     
  • Nasdaq

    13,307.77
    +88.45 (+0.67%)
     
  • Gold

    1,839.50
    -7.70 (-0.42%)
     
  • Crude Oil

    88.19
    -0.63 (-0.71%)
     
  • 10-Yr Bond

    4.6830
    +0.1100 (+2.41%)
     
  • FTSE Bursa Malaysia

    1,419.70
    +0.94 (+0.07%)
     
  • Jakarta Composite Index

    6,961.46
    +21.57 (+0.31%)
     
  • PSE Index

    6,304.53
    -16.71 (-0.26%)
     

COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?

COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?

The number of people with COVID-19 has been rising rapidly in China in recent weeks, and there are concerns that the government in Beijing could consider reviving its strict lockdown policies again. COVID-19 cases have been surging in China, largely due to the spread of the omicron XBB variants. In February, the Centers for Disease Control and Prevention pointed to early study results showing that for the bivalent vaccine boosters created to target omicron variants, "[vaccine effectiveness] was generally similar against BA.5-related infections [original omicron] and XBB/XBB.1.5-related infections."